Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
Go back to Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026| (NASDAQ: DNLI) | Delayed: 21.37 -0.71 (3.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.08 | 52 Week High | $ | |||
| Open | $21.69 | 52 Week Low | $ | |||
| Day High | $21.86 | P/E | N/A | |||
| Day Low | $21.34 | EPS | $ | |||
| Volume | 515,038 | |||||

